INSIGHTEC, an incisionless surgery company led by Maurice R. Ferré, announced Friday it had that received an investment of up to $150 million that will value it at $1.3 billion.
That makes it Miami’s latest “unicorn,” or a company worth at least 10 figures in tech parlance.
INSIGHTEC’s technology is an FDA-approved focused-ultrasound device that is primarily used to treat essential tremor, the most common movement disorder; and tremor-dominant Parkinson’s disease. The company was founded in 1999 in Israel; in 2014, it brought on Ferré, a co-founder of MAKO Surgical, as executive chairman. Ferré was named INSIGHTEC CEO in 2016. He is the son of former Miami Mayor Maurice A. Ferré.
